Herpes Zoster: Postherpetic Neuralgia and Other Complications (Post nr. 3360)

MARC-detaljer
000 -LEADER
fixed length control field	05487nam a22004935i 4500
001 - CONTROL NUMBER
control field	60185
005 - DATE AND TIME OF LATEST TRANSACTION
control field	20200226102408.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field	cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field	170405s2017 gw \| s \|\|\|\| 0\|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number	9783319443485
--	978-3-319-44348-5
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code	10.1007/978-3-319-44348-5
Source of number or code	doi
035 ## - SYSTEM CONTROL NUMBER
System control number	(DE-He213)978-3-319-44348-5
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number	RB127
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number	RD78.3-87.3
072 #7 - SUBJECT CATEGORY CODE
Subject category code	MMBP
Source	bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code	MED093000
Source	bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number	616.0472
Edition number	23
245 10 - TITLE STATEMENT
Title	Herpes Zoster: Postherpetic Neuralgia and Other Complications
Medium	[electronic resource] :
Remainder of title	Focus on Treatment and Prevention /
Statement of responsibility, etc.	edited by C. Peter N. Watson, Anne A. Gershon, Michael N. Oxman.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture	Cham :
Name of producer, publisher, distributor, manufacturer	Springer International Publishing :
--	Imprint: Adis,
Date of production, publication, distribution, manufacture, or copyright notice	2017.
300 ## - PHYSICAL DESCRIPTION
Extent	XXXIX, 431 p. 83 illus., 59 illus. in color.
Other physical details	online resource.
336 ## - CONTENT TYPE
Content type term	text
Content type code	txt
Source	rdacontent
337 ## - MEDIA TYPE
Media type term	computer
Media type code	c
Source	rdamedia
338 ## - CARRIER TYPE
Carrier type term	online resource
Carrier type code	cr
Source	rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type	text file
Encoding format	PDF
Source	rda
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note	1. Introduction -- 2. Varicella -- 3. Herpes Zoster: A Patient’s Perspective -- 4. The Epidemiology and Natural History of Herpes Zoster and Postherpetic Neuralgia -- 5. Herpes Zoster Ophthalmicus -- 6. Neurological Complications of Herpes Zoster -- 7. The Role of Varicella Zoster Virus in Giant cell Arteritis -- 8. Herpes Zoster and Vascular Risk -- 9. Antiviral Therapy and Local Treatment for Herpes Zoster -- 10. Dermatologic Manifestations of Herpes Zoster -- 11. The Effect of Herpes Zoster and Postherpetic Neuralgia on Health- Related Quality of Life, Function, Employment-Related Productivity, and the Cost Effectiveness of the Vaccine -- 12. The Pathology of Post-Herpetic Neuralgia and Postherpetic Itch -- 13. Neural Basis of Pain in Herpes Zoster and Postherpetic Neuralgia: the Ectopic Pacemaker Hypothesis -- 14. Persistent VZV Ganglionitis may be the Cause of Postherpetic Neuralgia -- 15. A Comparison of Clinical Features, and Mechanisms of Trigeminal Postherpetic Neuralgia and Trigeminal Neuralgia -- 16. Treatment of Post-Herpetic Neuralgia: Subtypes and a Mechanism-Based Treatment -- 17. Interventional Approaches to Postherpetic Neuralgia -- 18. Treatment of Post-Herpetic Neuralgia: The Role of Opioids -- 19. Postherpetic Neuralgia: Difficult to Treat, Easier to Prevent -- 20. Postherpetic Neuralgia: are There Neurosurgical Options? -- 21. Designing Randomized Controlled Trials of Oral Analgesics for Chronic Postherpetic Neuralgia -- 22. The Importance of Zoster Prevention Vaccines -- 23. Aggressive Non-Invasive Treatment of Acute Herpes Zoster for the Prevention of Postherpetic Neuralgia -- 24. Herpes Zoster Vaccines -- 25. Conclusion.
520 ## - SUMMARY, ETC.
Summary, etc.	Representing a state-of-the-art appraisal of this viral infection and its complications, this book comprises contributions from international authorities in infectious diseases and neuropathic pain. Important new information is presented on the role of the virus in terms of vascular risk, notably in heart attack, stroke and granulomatous angiitis (temporal arteritis). Similarly, new information on gastrointestinal involvement, often in the absence of rash and as seen with vasculopathies, is covered. The reader will benefit from new research into the pathology, pathophysiology and treatment of postherpetic neuralgia and its complications, and special attention is paid to prevention through zoster vaccination using the current vaccine, and a novel, broader option that can be used in immunocompromised patients. This books follows the two editions of the book, Herpes Zoster and Postherpetic Neuralgia, and is divided into sections for the convenience of the reader. A section on herpes zoster includes epidemiology and natural history of the varicella zoster virus, herpes zoster ophthalmicus, neurological complications, the role of varicella zoster virus in giant cell arteritis, concern about increased vascular risk of heart attack and stroke, antiviral therapy, and treatment of skin manifestations. A section on postherpetic neuralgia includes important information on the effect of herpes zoster and postherpetic neuralgia on quality of life, the neuropathology and pathophysiological mechanisms in postherpetic neuralgia, and the new concept of persistent ganglionitis as the cause of postherpetic neuralgia. A comparison is made between facial postherpetic neuralgia and trigeminal neuralgia. There is an extensive section on treatment, including the role of opioids, the general treatment of postherpetic neuralgia, intervention and neurosurgical approaches, and covering guidelines for clinical trial designs in postherpetic neuralgia. A final section addresses the questions of whether aggressive treatment of acute herpes zoster can prevent postherpetic neuralgia and includes a critically important chapter on herpes zoster vaccines.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Virology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Pain medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Pharmacotherapy.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Medicine & Public Health.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Pain medicine.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Virology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Pharmacotherapy.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name	Watson, C. Peter N.
Relator term	editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name	Gershon, Anne A.
Relator term	editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name	Oxman, Michael N.
Relator term	editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element	SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title	Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information	Printed edition:
International Standard Book Number	9783319443461
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier	<a href="http://dx.doi.org/10.1007/978-3-319-44348-5">http://dx.doi.org/10.1007/978-3-319-44348-5</a>
912 ## -
--	ZDB-2-SME

Inga exemplar finns tillgängliga.